Popular Articles

Pioneering Research Benefits The West Midlands, UK
Top researchers from the West Midlands are working to improve the treatment of conditions that affect millions of people. Across the region research into areas such as osteoarthritis, joint pain and sciatica, stroke prevention and treatment, community care for people living with diabetes, and the treatment of liver disease have received a real boost over the last three years.
new payday loan lenders
HPV Testing For Cervical Screening Investigated
New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
News of the day
Optical Chip Detects Blood Molecules
A portable "lab on a chip" that can identify target molecules in blood samples has been created by European researchers. It is being used to measure fertility hormones and detect the genes associated with certain types of cancer.
Oncology

Accouncing The Leading European Congress On Cardiac Arrhythmias And Pacing: EUROPACE 2009

EUROPACE, the official congress of the European Heart Rhythm Association (EHRA), is the foremost European meeting on cardiac arrhythmias and pacing. More than 4,000 participants are expected to attend this year"s event, whose main themes are atrial fibrillation and sudden cardiac death. EHRA is a registered branch of the European Society of Cardiology (ESC). Its mission is to reduce the impact of cardiac arrhythmias and sudden cardiac death (SCD). EUROPACE 2009 will be held from 21-24 June in ICC Berlin, Germany. The press conference in Berlin will highlight several themes from the EUROPACE 2009 scientific programme: * How to improve the quality of care with a more uniform treatment of arrhythmias and better prevention of sudden cardiac death in all European countries. * Cardiac arrhythmias in athletes will be another important topic. A scientific session will consider the requirement for screening of all athletes to avoid sudden cardiac death and the implications of an abnormal electrocardiogram (ECG) in an athlete. The prevalence of cardiac arrhythmias in the athlete"s heart will be debated. * Hot Line sessions will be a major feature at EUROPACE 2009 (Tuesday 23 June). Devoted to late-breaking news from clinical trials, the ESC"s Hot Line sessions are renowned for making strong stories in medical news and will be discussed at the press conference. Also presented at the press conference: * Remote monitoring * Latest facts and figures on arrhythmias in Europe * Driving with ICD * Beat-It! Campaign Notes: 1. Sudden cardiac death claims more lives than stroke, lung cancer, breast cancer and AIDS combined. Incidence is less than 1% per year in the general population, but rising to more than 30% in high-risk post-MI subgroups. 2. Cardiac arrhythmia describes conditions in which heart beat is too fast, too slow, or irregular. The cause is abnormal electrical activity in the heart. Some arrhythmias may be life-threatening and result in sudden cardiac death. The average healthy heart beats 200,000 times per day. 3. The most common arrhythmia (after a skipped beat) is atrial fibrillation, which affects up to 5 per cent of all adults, mainly the over-65s. * Information on the scientific programme for Europace 2009 is available at http://spo.escardio.org/Welcome.aspx?eevtid=32 ESC Press Office European Society of Cardiology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):